Sophie Trefely has been a group leader at the Babraham Institute since January 2022. She completed her PhD training researching insulin action with David James at the Garvan Institute of Medical Research, Sydney in 2015. Her post-doctoral training focussed on metabolite signalling and was jointly between the labs of Kathryn Wellen and Nathaniel Snyder, at the University of Pennsylvania.